Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2026-01-26 @ 9:09 AM
Study NCT ID:
NCT03522259
Status:
COMPLETED
Last Update Posted:
2024-11-13
First Post:
2018-04-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery
Sponsor:
Insel Gruppe AG, University Hospital Bern
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UVCMBS003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None